These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 31559376)
1. Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α' Structures. Lindenblatt D; Nickelsen A; Applegate VM; Hochscherf J; Witulski B; Bouaziz Z; Marminon C; Bretner M; Le Borgne M; Jose J; Niefind K ACS Omega; 2019 Mar; 4(3):5471-5478. PubMed ID: 31559376 [TBL] [Abstract][Full Text] [Related]
2. Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'. Hochscherf J; Lindenblatt D; Witulski B; Birus R; Aichele D; Marminon C; Bouaziz Z; Le Borgne M; Jose J; Niefind K Pharmaceuticals (Basel); 2017 Dec; 10(4):. PubMed ID: 29236079 [TBL] [Abstract][Full Text] [Related]
3. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'. Bollacke A; Nienberg C; Borgne ML; Jose J J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382 [TBL] [Abstract][Full Text] [Related]
4. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β. Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709 [TBL] [Abstract][Full Text] [Related]
5. Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'. Bischoff N; Raaf J; Olsen B; Bretner M; Issinger OG; Niefind K Mol Cell Biochem; 2011 Oct; 356(1-2):57-65. PubMed ID: 21739153 [TBL] [Abstract][Full Text] [Related]
6. Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor. Niefind K; Bischoff N; Golub AG; Bdzhola VG; Balanda AO; Prykhod'ko AO; Yarmoluk SM Pharmaceuticals (Basel); 2017 Jan; 10(1):. PubMed ID: 28085026 [TBL] [Abstract][Full Text] [Related]
7. Inducible expression of protein kinase CK2 in mammalian cells. Evidence for functional specialization of CK2 isoforms. Vilk G; Saulnier RB; St Pierre R; Litchfield DW J Biol Chem; 1999 May; 274(20):14406-14. PubMed ID: 10318865 [TBL] [Abstract][Full Text] [Related]
8. Discovery of a CK2α'-Biased ATP-Competitive Inhibitor from a High-Throughput Screen of an Allosteric-Inhibitor-Like Compound Library. Mudaliar D; Mansky RH; White A; Baudhuin G; Hawkinson J; Wong H; Walters MA; Gomez-Pastor R ACS Chem Neurosci; 2024 Aug; 15(15):2703-2718. PubMed ID: 38908003 [TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of the CK2alpha'-based holoenzyme, an isozyme of CK2alpha: a comparative analysis. Olsen BB; Boldyreff B; Niefind K; Issinger OG Protein Expr Purif; 2006 Jun; 47(2):651-61. PubMed ID: 16442308 [TBL] [Abstract][Full Text] [Related]
10. Identification of CK2α' selective inhibitors by the screening of an allosteric-kinase-inhibitor-like compound library. Mudaliar D; Mansky RH; White A; Baudhuin G; Hawkinson J; Wong H; Walters MA; Gomez-Pastor R bioRxiv; 2024 Jan; ():. PubMed ID: 38328231 [TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes. Olsen BB; Rasmussen T; Niefind K; Issinger OG Mol Cell Biochem; 2008 Sep; 316(1-2):37-47. PubMed ID: 18574672 [TBL] [Abstract][Full Text] [Related]
12. Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity. Lindenblatt D; Applegate V; Nickelsen A; Klußmann M; Neundorf I; Götz C; Jose J; Niefind K J Med Chem; 2022 Jan; 65(2):1302-1312. PubMed ID: 34323071 [TBL] [Abstract][Full Text] [Related]
13. Differential localization of alpha' and beta subunits of protein kinase CK2 during rat spermatogenesis. Alvarado-Díaz CP; Tapia JC; Antonelli M; Moreno RD Cell Tissue Res; 2009 Oct; 338(1):139-49. PubMed ID: 19711102 [TBL] [Abstract][Full Text] [Related]
14. Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners. Litchfield DW; Bosc DG; Canton DA; Saulnier RB; Vilk G; Zhang C Mol Cell Biochem; 2001 Nov; 227(1-2):21-9. PubMed ID: 11827170 [TBL] [Abstract][Full Text] [Related]
15. Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival. Turowec JP; Vilk G; Gabriel M; Litchfield DW Oncotarget; 2013 Apr; 4(4):560-71. PubMed ID: 23599180 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. Ermakova I; Boldyreff B; Issinger OG; Niefind K J Mol Biol; 2003 Jul; 330(5):925-34. PubMed ID: 12860116 [TBL] [Abstract][Full Text] [Related]
17. A N-terminally deleted form of the CK2α' catalytic subunit is sufficient to support cell viability. Borgo C; D'Amore C; Cesaro L; Itami K; Hirota T; Salvi M; Pinna LA Biochem Biophys Res Commun; 2020 Oct; 531(3):409-415. PubMed ID: 32800562 [TBL] [Abstract][Full Text] [Related]
18. Expression and regulation of protein kinase CK2 during the cell cycle. Bosc DG; Lüscher B; Litchfield DW Mol Cell Biochem; 1999 Jan; 191(1-2):213-22. PubMed ID: 10094411 [TBL] [Abstract][Full Text] [Related]
19. Protein Kinase CK2α', More than a Backup of CK2α. Montenarh M; Götz C Cells; 2023 Dec; 12(24):. PubMed ID: 38132153 [TBL] [Abstract][Full Text] [Related]
20. First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2. Raaf J; Issinger OG; Niefind K J Mol Biol; 2009 Mar; 386(5):1212-21. PubMed ID: 19361447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]